Fig. 9

Decrease of CX3CR1 expression in VPS35^CX3CR1 cortex after ischemic stroke. a Western blot analysis. At day 3 after stroke, the homogenates from contralateral (con) and ipsilateral (ipsi) cortical brains and hippocampus were subjected to Western blot analysis using indicated antibodies. b Quantification analysis of data in (a) for CX3CR1 protein levels (mean ± SEM; n = 3/group; *P < 0.05). c Co-immunostaining analysis using antibodies against CX3CR1 and GFP in ipsilateral cortical peri­infarct area. d Quantification analyses of data in (c) (mean ± SEM; n = 3/group; *P < 0.05)